ScPharmaceuticals to Announce First Quarter 2024 Financial Results On Tuesday, May 14, 2024
ScPharmaceuticals to Announce First Quarter 2024 Financial Results On Tuesday, May 14, 2024
Management to host conference call and webcast at 4:30 p.m. ET
管理层将在美国东部时间下午 4:30 主持电话会议和网络直播
BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Tuesday, May 14th, 2024, to discuss the financial results for the first quarter 2024 and provide a business update.
马萨诸塞州伯灵顿，2024年5月7日（GLOBE NEWSWIRE）——专注于开发和商业化具有优化疗法、促进患者护理和降低医疗成本潜力的产品的制药公司SCPHarmicals Inc.（纳斯达克股票代码：SCPH）今天宣布，SCPHarmicals管理层将于美国东部时间5月14日星期二下午 4:30 举办电话会议和网络音频直播第四，2024年，讨论2024年第一季度的财务业绩并提供业务最新情况。
Participants should dial 1-800-717-1738 (domestic) or 1-646-307-1865 (international) with the conference code 89054.
参与者应拨打 1-800-717-1738（国内）或 1-646-307-1865（国际），会议代码为 89054。
To access the Call Me feature, which avoids having to wait for an operator, click here.
要访问 “给我打电话” 功能，无需等待接线员，请单击此处。
The live webcast and replay of the conference call can be accessed here or under "News & Events" in the Investor Relations section of the Company's website, .
可以在此处或公司网站投资者关系部分的 “新闻与活动” 下观看电话会议的网络直播和重播。
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead program focuses on the subcutaneous, self-administration of IV-strength treatment in heart failure. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit .
关于 SC 制药
SCPharmaceuticals是一家制药公司，专注于开发和商业化旨在降低医疗成本和改善健康状况的产品。该公司在内部和通过战略合作伙伴关系开发创新的产品和解决方案，旨在扩大和推进特定急性疾病的门诊护理。该公司的牵头项目侧重于心力衰竭的静脉注射强度治疗的皮下自我给药。scPharmicals总部位于马萨诸塞州伯灵顿。欲了解更多信息，请访问。
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
凯瑟琳米兰
SCpharmicals Inc.，781-301-6869
kmiranda@scpharma.com
Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com
投资者：
PJ Kelleher
LifeSci 顾问，617-430-7579
pkelleher@lifesciadvisors.com
译文内容由第三方软件翻译。